Investment highlights growing interest in Cartography’s oncology pipeline and platform –SOUTH SAN FRANCISCO, Calif. & SEOUL, South Korea--(BUSINESS WIRE)--Cartography Biosciences and Samsung Ventures ...

Year in the First QuarterCompany Raises Full Year 2026 Revenue and Adjusted EBITDA ExpectationsSANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” ...

Award-winning SDS management software automates chemical safety compliance by delivering AI-powered SDS automation directly into SAP workflowsCARLSBAD, Calif.--(BUSINESS WIRE)--3E, a global leader in ...

Global strategic collaboration with Astellas to advance PSMA-targeted, PRO-XTEN® dual-masked T-cell engager (TCE) VIR-5500 closed and first patient dosed in Phase 1 dose-expansion cohorts in patients ...

Regulatory filings are under review in the U.S., Europe, Canada and Australia, with potential approvals expected to begin in 2026 CAMBRIDGE, MA / ACCESS Newswire / May 6, 2026 / Moderna, Inc.

Proceeds to support registration-enabling trials, DOMMINO-1 and DOMMINO-2, and continued development of the first-in-class p300/CBP inhibitorFinancing led by Venrock Healthcare Capital Partners, with ...

Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the first quarter ended March ...

Innovation wins 2026 DIELINE Award with Clarins Total Eye Lift for ‘Sustainable Design – Health, Body & Beauty’CRYSTAL LAKE, ...

Net product revenues for the first quarter 2026 totaled $330.5 million, consisting of $102.0 million of ELEVIDYS net product revenue and $228.6 million of PMO net product revenuesAchieved GAAP and non ...

Net sales increased to $31.5 millionGross margin improved to 63.5%Net income of $6.3 million, up $1.3 million from the prior ...

Net sales rise 2% to $492 million on a reported basis, and -1% at constant exchange rates (CER) vs. outlook for at least 1% ...

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, ...